Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 13, 2004
Controversies in the radiotherapeutic management of poor prognosis locally advanced prostate cancerA M Henry, P Price, J P Logue, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 17, 2007
Recto-urethral fistula following brachytherapy for localized prostate cancerD Shakespeare, D M Mitchell, B M Carey, et al.
The British Journal of Radiology|July 28, 2005
An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging deviceA M Henry, J Stratford, J Davies, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 11, 2014
Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancerH Musunuru, M Mason, L Murray, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 26, 2015
The Effect of Dose and Quality Assurance in Early Prostate Cancer Treated with Low Dose Rate Brachytherapy as MonotherapyA M Henry, S L Rodda, M Mason, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 24, 2018
Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate CancerS Parikh, L Murray, L Kenning, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 20, 2026
Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial DesignF Slevin, S Kendal, A L Appelt, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 11, 2026
Reirradiation Options for Previously Irradiated Prostate Cancer: Is It Feasible to Randomise Between Treatment With Stereotactic Body Radiotherapy (SBRT) Versus High-Dose-Rate Brachytherapy?J Zhong, F Slevin, S Brown, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 20, 2026
Clinical Oncologist and NHS Commissioner Perspectives on Reirradiation for Recurrent CancerF Slevin, S Kendal, A L Appelt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2019
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†A Horwich, M Babjuk, J Bellmunt, et al.
Pageof 2